Anti-NMDA receptor encephalitis classification

Anti-NMDA receptor encephalitis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Anti-NMDA receptor encephalitis from Other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications, and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Anti-NMDA receptor encephalitis classification On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Anti-NMDA receptor encephalitis classification All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Anti-NMDA receptor encephalitis classification
CDC on Anti-NMDA receptor encephalitis classification
Anti-NMDA receptor encephalitis classification in the news
Blogs on Anti-NMDA receptor encephalitis classification
Directions to Hospitals Treating Anti-NMDA receptor encephalitis
Risk calculators and risk factors for Anti-NMDA receptor encephalitis classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; AE Dheeraj Makkar, M.D.[2]

Classification

Anti NMDA Encephalitis may be classified into three subtypes, depending on the timing of presentation and duration.

Subtype	Symptoms	Duration
Class 1	Primarily catatonic or stuporous state	Less than 60 days
Class 2	Primarily psychotic state	More than 60 days
Class 3	Primarily catatonic or stuporous state	More than 60 days